Literature DB >> 19095506

Preinductive use of clonidine and ketamine improves recovery and reduces postoperative pain after bariatric surgery.

Liliana Sollazzi1, Cristina Modesti, Francesca Vitale, Teresa Sacco, Pierpaolo Ciocchetti, Anna Sara Idra, Roberto Maria Tacchino, Valter Perilli.   

Abstract

BACKGROUND: In obese patients, concomitant use of clonidine and ketamine might be suitable to reduce the doses and minimize the undesired side effects of anesthetic and analgesic drugs. In this study, we evaluated the perioperative effects of administration of clonidine and ketamine in morbidly obese patients undergoing weight loss surgery at a university hospital in Rome, Italy.
METHODS: A total of 50 morbidly obese patients undergoing open biliopancreatic diversion for weight loss surgery were enrolled. The patients were randomly allocated into a study group (n = 23) receiving a slow infusion of ketamine-clonidine before anesthesia induction and a control group (n = 27) who received standard anesthesia. The hemodynamic profile, intraoperative end-tidal sevoflurane and opioid consumption, tracheal extubation time, Aldrete score, postoperative pain assessment by visual analog scale, and analgesic requirements were recorded.
RESULTS: The patients in the study group required less end-tidal sevoflurane, lower total doses of fentanyl (3.8 +/- 0.3 gamma/kg actual body weight versus 5.0 +/- 0.2 gamma/kg actual body weight, respectively; P <.05) and had a shorter time to extubation (15.1 +/- 5 min versus 28.2 +/- 6 min, P <.05). The Aldrete score was significantly better in the postanesthesia care unit in the study group. The study group consumed less tramadol than did the control group (138 +/- 57 mg versus 252 +/- 78 mg, P <.05) and had a lower visual analog scale score postoperatively during the first 6 hours.
CONCLUSION: The preoperative administration of low doses of ketamine and clonidine at induction appears to provide early extubation and diminished postoperative analgesic requirements in morbidly obese patients undergoing open bariatric surgery.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19095506     DOI: 10.1016/j.soard.2008.09.018

Source DB:  PubMed          Journal:  Surg Obes Relat Dis        ISSN: 1550-7289            Impact factor:   4.734


  10 in total

Review 1.  Controversies in perioperative anesthetic management of the morbidly obese: I am a surgeon, why should I care?

Authors:  Ashish C Sinha; Preet Mohinder Singh
Journal:  Obes Surg       Date:  2015-05       Impact factor: 4.129

2.  Does obesity affect outcomes in patients undergoing esophagectomy for cancer? A meta-analysis.

Authors:  Babar Kayani; Koji Okabayashi; Hutan Ashrafian; Leanne Harling; Christopher Rao; Ara Darzi; Yuko Kitagawa; Thanos Athanasiou; Emmanouil Zacharakis
Journal:  World J Surg       Date:  2012-08       Impact factor: 3.352

Review 3.  Ketamine as a component of multimodal analgesia for pain management in bariatric surgery: A systematic review and meta-analysis of randomized controlled trials.

Authors:  Mohamed Ali Mohamed Ali Chaouch; Mohamed Aziz Daghmouri; Marie-Christine Boutron; Jean-Marc Ferraz; Sofia Usai; Olivier Soubrane; Marc Beaussier; Guillaume Pourcher; Hani Oweira
Journal:  Ann Med Surg (Lond)       Date:  2022-05-14

Review 4.  Challenges in the optimisation of post-operative pain management with opioids in obese patients: a literature review.

Authors:  C Lloret-Linares; A Lopes; X Declèves; A Serrie; S Mouly; J-F Bergmann; S Perrot
Journal:  Obes Surg       Date:  2013-09       Impact factor: 4.129

5.  Perioperative intravenous ketamine for acute postoperative pain in adults.

Authors:  Elina Cv Brinck; Elina Tiippana; Michael Heesen; Rae Frances Bell; Sebastian Straube; R Andrew Moore; Vesa Kontinen
Journal:  Cochrane Database Syst Rev       Date:  2018-12-20

6.  Society of Anesthesia and Sleep Medicine Guideline on Intraoperative Management of Adult Patients With Obstructive Sleep Apnea.

Authors:  Stavros G Memtsoudis; Crispiana Cozowicz; Mahesh Nagappa; Jean Wong; Girish P Joshi; David T Wong; Anthony G Doufas; Meltem Yilmaz; Mark H Stein; Megan L Krajewski; Mandeep Singh; Lukas Pichler; Satya Krishna Ramachandran; Frances Chung
Journal:  Anesth Analg       Date:  2018-10       Impact factor: 5.108

7.  Prolonged ketamine infusion modulates limbic connectivity and induces sustained remission of treatment-resistant depression.

Authors:  Joshua S Siegel; Ben J A Palanca; Beau M Ances; Evan D Kharasch; Julie A Schweiger; Michael D Yingling; Abraham Z Snyder; Ginger E Nicol; Eric J Lenze; Nuri B Farber
Journal:  Psychopharmacology (Berl)       Date:  2021-01-22       Impact factor: 4.530

Review 8.  Ketamine-New Possibilities in the Treatment of Depression: A Narrative Review.

Authors:  Mateusz Kowalczyk; Edward Kowalczyk; Paweł Kwiatkowski; Łukasz Łopusiewicz; Monika Sienkiewicz; Monika Talarowska
Journal:  Life (Basel)       Date:  2021-11-05

Review 9.  Enhanced recovery after bariatric surgery: an Italian consensus statement.

Authors:  Giuseppe Marinari; Mirto Foletto; Carlo Nagliati; Giuseppe Navarra; Vincenzo Borrelli; Vincenzo Bruni; Giovanni Fantola; Roberto Moroni; Luigi Tritapepe; Roberta Monzani; Daniela Sanna; Michele Carron; Rita Cataldo
Journal:  Surg Endosc       Date:  2022-08-11       Impact factor: 3.453

10.  Low-Dose Ketamine Infusion for Perioperative Pain Management in Patients Undergoing Laparoscopic Gastric Bypass: A Prospective Randomized Controlled Trial.

Authors:  Mitchell T Seman; Shawn H Malan; Matthew R Buras; Richard J Butterfield; Kristi L Harold; James A Madura; David M Rosenfeld; Andrew W Gorlin
Journal:  Anesthesiol Res Pract       Date:  2021-07-21
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.